#$%^&*AU2019236714A120191017.pdf#####ABSTRACT The invention relates to 7-aminocephalosporanic acid derivative, Cefazolin, for use as the inhibitor of IL-15 and IL-2 receptors in the prevention and treatment of IL-15 and IL-2 overproduction related diseases.